What is the main business of Apteka Eskulap?

The main business activity of Apteka Eskulap focuses on dispensing chemist in specialised stores.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on March 22, 2017.

Where is the headquarters located?

The headquarters is located at: ul. Kościelna 19, 21-200 Parczew.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

In 2025, the company generated total revenue of $598,689, representing a decrease of 5.6% compared to 2024.

No, in 2025 the company was not profitable, reporting a net loss of $5,940.

Which cost dominates operating expenses?

The largest operating cost category falls under other operating costs. This category amounted to $446,674 in 2025, representing 75% of all operating expenses.

Apteka Eskulapsp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2017-03-22

Share capital

5,000.00 PLN

Registered address

ul. Kościelna 19, 21-200 Parczew, Poland

Electronic delivery address

AE:PL-99950-12435-EDRIB-13

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 54 days early.

202508/06/2026
202429/05/2025
202327/05/2024
202213/06/2023
202111/05/2022
202012/07/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 598.69kMedianUSD 1.92mAverageUSD 5.20m

Net profit

This companyUSD -5.94kMedianUSD 20.66kAverageUSD 86.55k

Operating costs

This companyUSD 596.87kMedianUSD 1.88mAverageUSD 5.04m

Assets

This companyUSD 192.00kMedianUSD 544.32kAverageUSD 1.76m

Industry

National Health Fund (NFZ) contracts

Apteka Eskulap has been an NFZ healthcare provider since 2008. In 2026 it is performing 2 contracts with a total value of USD 21.81k. All its contracts were worth USD 45.91k in total.

NFZ contract value by year (in k USD)

Type of care	NFZ branch	Contracts	Value in 2026
Other services provided in pharmacies	lubelskie	1	USD 21.81k
Provision of medical devices	lubelskie	1	USD 0.00

Authorized Representatives

Paweł Pyza – President of the Management Board

Manner of representation

In the case of a multi-member management board, the joint action of two members of the management board is required. In the case of a one-person management board, the only member of the management board is authorised to make declarations on behalf of the company.

Ownership

Owner	Shares	Share value	Stake
Eramedica sp. z o.o.	100	$1,350.62	100%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2017-06-01.

PKO Bank Polski
70 1020 3206 0000 8102 0005 6002

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

Name	Revenue	Website
Fragalsp. z o.o.	$5,374,285.81	aptekafragal.pl
Modrzewscysp. j.	$5,602,358.99	aptekacentrum.lublin.pl
MaglowS.A.	$1,356,219.12	maglow.pl
Farmacja Im. O. Klimuszkisp. z o.o.	$1,289,548.20	zyj-zdrowo.com
Twoja Tania Apteka Farmarsp. z o.o.	$440,843.57	domlekow.pl
Nukloversp. z o.o.	$227,479.26	nuklover.com
Massmedsp. z o.o.	$49,747.70	mojoapps.co
Pharmer Polskasp. z o.o.	$15,884.06	punktapteczny.online
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.	$2,740.83	kwendasa.pl
Femaherbsp. z o.o.	$655.76	femaherb.com